The observation of the efficacy of alprostadil combined with shenkang injection for the of treatment of chronic renal failure

Abstract

Objective To investigate the clinical efficacy and value of alprostadil combined with Shenkang injection in treatment for chronic renal failure (CRF).Methods 92 patients with CRF were randomly divided into observation group and control group,with 46 cases in each group,the control group was given antiinfection,control blood pressure,diet and other conventional treatment,on the basis of conventional therapy observation group was treated with alprostadil Shenkang injection fluid treatment program,patients were observed with clinical efficacy.Results After treatment,all biochemical indicators in the observation group were better than those of the control group (P＜0.05); the total effective rate was 89.13％,significantly higher than that of the control group (54.35％) (P＜0.05).Conclusion The combination therapy of alprostadil and Shenkang injection for CRF can effectively improve the clinical symptoms and delay kidney failure process,and has no adverse reaction,which can be used as a preferred option for the conservative treatment of CRF. Key words: Alprostadil; Shenkang injection; Chronic renal failure (CRF)